Industry Overview

Global direct-to-consumer laboratory testing market was valued at USD XX Mn in 2020 and is expected to grow at a CAGR of XX% during 2021–2030 to reach XX Mn by the year 2030. The market growth is attributed to the increasing awareness among end-user about regular health checkups and the importance of testing in minimizing potential health emergencies. Increasing investment by major market players to reduce the testing time is projected to emerge as a key market driver over the forecast period.

Introduction

Direct-to-consumer testing is a process where users can receive the laboratory test result without the involvement of healthcare providers. This process requires the user to send the sample of their urine or saliva to a laboratory for analysis.

Researchers and medical practitioners have been able to the reduced cost involved in the overall medical examination using the DTC test as a result increasing burden on healthcare infrastructures are expected to reduce at a substantial rate.

Consumers are becoming more health-conscious and eager to participate more in the decision-making and management of their healthcare. As a result, consumers and healthcare practitioners are becoming interested in direct-to-consumer testing (DTCs). The market for DTCs has grown substantially for the last several years and is likely to continue to expand in the forecast period.

Data Protection Laws such as the US Genetic Information Non-discrimination Act (2008) provide customers with a level of comfort by disallowing results to impact health insurance policies and employment which is expected to boost the demand for direct to consumer laboratory testing market in US.

Direct-to-Consumer Laboratory Testing Market Covid-19 Pandemic Impact & Recovery Analysis

COVID-19 Pandemic affected the global economy adversely in the year 2020, and continue to create major challenges for healthcare facilities in the year 2021. However, the direct-to-consumer laboratory testing market registered significant demand throughout the period.

One strategy to contain the COVID-19 pandemic is extensive diagnostic and serological (antibody) testing. While most COVID-19 diagnostic testing in the United States was undertaken in hospital settings initially, a direct-to-consumer (DTC) testing business rapidly developed. The test is initiated by the customer, and the sample is collected at home or at a commercial laboratory under these DTC service models. Although there are potential benefits to providing DTC tests, such as broadening access to testing and lowering the risk of exposure for consumers and medical workers, it also poses substantial ethical and regulatory problems.

Know how Covid-19 pandemic affected market growth: Order Free Sample & Covid-19 pandemics impact & recovery analysis

Direct-to-Consumer Laboratory Testing Market Dynamics

Personalized data for health, future disease risk, and potential health issues

The direct-to-consumer laboratory testing market is gaining popularity among the end-users owing to its capabilities to provide easy access to personalized health-related medical data. Obesity, hypertension, diabetes, cancer, and STDs are among the lifestyle-related and infectious disorders that have become more common. The need for direct-to-consumer (DTC) laboratory testing for early diagnosis is projected to rise as a result. Heart disorders cause over 655,000 deaths in the United States each year, according to the Centers for Disease Control and Prevention. Cancer is the primary cause of death worldwide. The majority of cancer occurrences are caused by factors about one’s lifestyle. Various DTC test kits are available for testing and detecting disorders associated with health and lifestyle.

Increasing consumer demand for highly confidential tests

Consumers are becoming more conscious about personal health and increasing concern about health-related data security is among the top priority for users. Direct -to-consumer laboratory testing market is gaining popularity owing to its data privacy and high confidentiality standards which creates further scope for expanding test offerings.

Know how the market dynamics are projected to shift: Order Free Sample & Competition Landscape Mapping

Direct-to-Consumer Laboratory Testing Market Segment Analysis

The direct-to-consumer laboratory testing market is segmented by test type, by sample, by test provider, & by region.

Insights by Test Type

Based on taste type the market is segmented into Genetic testing, disease risk assessment testing, chronic disease testing, CBC, Covid-19 testing, THS testing, and others.

In the year 2020, the covid-19 testing segment accounted for the largest market share in terms of revenue owing to increasing demand for safety testing to reduce the potential spread of covid. Major market players introduce cost-effective and time-saving test offerings for consumers which are further projected to drive the segment growth in the coming years.

Chronic disease testing segment registered significant growth potential with CAGR of XX% over the period 2021-2030 and projected to dominate the market demand accounted for increasing cases of hypertension and diabetes among the developed and developing economies as a result of a busy lifestyle and changing food consumption habits.

Insights by Sample Type

Based on sample type the market is segmented into blood, saliva, urine, and other samples. In the year 2020, saliva sample testing accounted for the largest share in the direct-to-consumer laboratory testing market as a result of the COVID-19 pandemic and saliva testing fast result analysis capabilities.

However, the urine testing segment is projected to boost the market demand over the forecast period owing to increasing consumer demand for home comfort sample collection methods and increasing patients’ need to get health diagnoses for kidney diseases, diabetes, and urinary tract infections.

Know how the key market segments are projected to drive overall growth over the forecast period: Order Free Sample Report

Direct-to-Consumer Laboratory Testing Market Regional Analysis

North America led the direct-to-consumer laboratory testing market in the year 2020 and is projected to hold its dominance over the forecast period 2021-2030 accounted for increasing demand for rapid tests with convenience and the growing prevalence of diseases such as diabetes and hypertension in the region.

In the recent few years, there has been a significant shift in the tendency toward home-based diagnostic equipment in the United States. Pixel by LabCorp, for example, offered a self-collected testing kit for health, heart disease, diabetes, and colorectal cancer in November 2018. Apart from product launches, numerous market participants are pursuing various company expansion methods such as mergers and acquisitions, as well as partnerships and collaborations with other companies and prominent diagnostic laboratories which is expected to drive the market in North America.

Market growth in Europe is hampered by government regulations to conduct laboratory testing without the involvement of healthcare facilities. However, specific testing permissions and consumer demand is projected to drive the market demand in the coming years.

Know how MICRO & MACRO factors are impacting the regional growth: Order Free Sample Report

Competitive Insights

The market is strongly competitive in nature with direct & indirect competitors focusing on leveraging growth opportunities to drive business. Major companies in the direct-to-consumer laboratory testing market include 23andMe, Color Genomics, Any Lab Test Now, Counsyl, Direct Laboratory Services, Gene by Gene, HealthCheckUSA, Home Access Health, Laboratory Corp, MyMedLab, Mapmygenome, Pathway Genomics, Positive Bioscience, Quest Diagnostics, Request A Test, Sonora Quest Labs, Theranos, Walk-in Lab, WellnessFX, Xcode Life Sciences, among others (20+ Companies are profile in the final report)

Key market players are focusing on mergers, acquisitions, partnerships, and joint ventures to gain a competitive edge in the direct-to-consumer laboratory testing market.

• In November, 23andME holding Co. completed the acquisition of Lemonaid Health Inc. which is an on-demand platform for pharmacy and medical care services enabling 23andME holding Co. to expand its market reach and provide affordable services to the consumers.

Know-how direct & Indirect competitors are leveraging growth trends & business strategies: Order Free Competition Landscape Mapping

Direct-to-Consumer Laboratory Testing Market Report Coverage

Global Direct-to-Consumer Laboratory Testing Market, by Test Type

• Genetic Testing
  • Lactose Intolerance
  • Nutrigenetics Test
  • Weight Control
  • Others
• Celiac Disease Test
  • General Health Testing
  • Sports and Physical Activity Testing
  • Women’s Health Tests
  • Pregnancy and Prenatal Screening
  • Men’s Health Tests
  • Others
• Disease Risk Assessment Testing
  • Sexual Health Tests
  • HIV
  • Chlamydia
  • Others
  • Cancer Predisposition Tests
  • Others
• CBC
• Chronic Disease Testing
  • Diabetes Testing
  • Hypertension
  • Others
• TSH Testing
• COVID-19 Testing
• Others

Global Direct-to-Consumer Laboratory Testing Market, by
Sample Type

• Saliva
• Urine
• Blood
• Others

Global Direct-to-Consumer Laboratory Testing Market, by
Provider

• Clinics
• Specialty Labs
• Hospitals
• Diagnostic Centers

Global Direct-to-Consumer Laboratory Testing Market, by Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
• Asia Pacific
  • China
  • South Korea
  • Japan
  • Australia
  • Malaysia
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates
  • South Africa
• South America
  • Brazil
  • Argentina